Literature DB >> 29325630

Towards precision medicine.

Tanya Bardakjian1, Pedro Gonzalez-Alegre2.   

Abstract

The concept of precision medicine, also referred to as individualized or personalized medicine, has recently gained traction in scientific, medical, and public spheres, and is frequently mentioned as the next model of healthcare delivery. Its goal is to integrate unique information obtained from a given patient to customize the care provided to achieve the best possible outcome. Although precision medicine is not fully implemented yet, its application is slowly infiltrating clinical practice, and the dream of individualizing healthcare to each patient is now closer to being fulfilled. This chapter summarizes the current status of personalized medicine in the neurology clinic, including precision diagnostics and individualized therapeutics. Subsequently, we address the main hurdles that the healthcare community needs to overcome to expand this model of healthcare delivery and predict how this evolving field will shape future neurologic practice.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  gene therapy; genetics; genomics; individualized; next generation; personalized; pharmacogenomics; precision

Mesh:

Year:  2018        PMID: 29325630     DOI: 10.1016/B978-0-444-63233-3.00008-7

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  4 in total

Review 1.  Machine learning as the new approach in understanding biomarkers of suicidal behavior.

Authors:  Alja Videtič Paska; Katarina Kouter
Journal:  Bosn J Basic Med Sci       Date:  2021-08-01       Impact factor: 3.363

Review 2.  Convergence of Precision Medicine and Public Health Into Precision Public Health: Toward a Big Data Perspective.

Authors:  Pedro Elkind Velmovitsky; Tatiana Bevilacqua; Paulo Alencar; Donald Cowan; Plinio Pelegrini Morita
Journal:  Front Public Health       Date:  2021-04-06

3.  Regional Radiomics Similarity Networks Reveal Distinct Subtypes and Abnormality Patterns in Mild Cognitive Impairment.

Authors:  Kun Zhao; Qiang Zheng; Martin Dyrba; Timothy Rittman; Ang Li; Tongtong Che; Pindong Chen; Yuqing Sun; Xiaopeng Kang; Qiongling Li; Bing Liu; Yong Liu; Shuyu Li
Journal:  Adv Sci (Weinh)       Date:  2022-01-31       Impact factor: 17.521

4.  iCEMIGE: Integration of CEll-morphometrics, MIcrobiome, and GEne biomarker signatures for risk stratification in breast cancers.

Authors:  Xuan-Yu Mao; Jesus Perez-Losada; Mar Abad; Marta Rodríguez-González; Cesar A Rodríguez; Jian-Hua Mao; Hang Chang
Journal:  World J Clin Oncol       Date:  2022-07-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.